Yates C M, Simpson J, Gordon A, Maloney A F, Allison Y, Ritchie I M, Urquhart A
Brain Res. 1983 Nov 28;280(1):119-26. doi: 10.1016/0006-8993(83)91179-4.
Noradrenaline, dopamine, homovanillic acid (HVA), choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) levels were measured in post-mortem brains from 8 cases of pre-senile Alzheimer-type dementia (ATD), 5 cases of senile ATD, 4 cases of Down's syndrome aged 53-57 years, one 27-year-old case of Down's syndrome and 13 controls. In the controls, the concentration of noradrenaline in hypothalamus (P less than 0.05) and mamillary body (P less than 0.02) decreased with age. Compared with age-matched controls, noradrenaline levels in these areas were more markedly reduced in pre-senile ATD (P less than 0.01), the 53-57-year-old cases of Down's syndrome (P less than 0.001) and in the 27-year-old Down's, than in senile ATD (hypothalamus P less than 0.05, mamillary body, n.s.). Dopamine and HVA concentrations in caudate nucleus were unaltered in pre-senile or senile ATD but dopamine was decreased (P less than 0.01) in the older cases, although not in the 27-year-old case, of Down's syndrome. In the olfactory tubercle in ATD the level of HVA was unaltered but the activity of ChAT was decreased (P less than 0.01). ChAT activity was reduced in pre-senile ATD (P less than 0.001), the older Down's cases (P less than 0.01) but not the young Down's case, and senile ATD (P less than 0.001) in the temporal cortex and in pre-senile ATD (P less than 0.001) and the older Down's cases (P less than 0.001) but not senile ATD in the caudate nucleus.(ABSTRACT TRUNCATED AT 250 WORDS)
对8例早老性阿尔茨海默型痴呆(ATD)、5例老年性ATD、4例年龄在53 - 57岁的唐氏综合征患者、1例27岁的唐氏综合征患者以及13名对照者的尸检大脑进行了去甲肾上腺素、多巴胺、高香草酸(HVA)、胆碱乙酰转移酶(ChAT)和乙酰胆碱酯酶(AChE)水平的检测。在对照组中,下丘脑(P < 0.05)和乳头体(P < 0.02)中的去甲肾上腺素浓度随年龄降低。与年龄匹配的对照组相比,这些区域的去甲肾上腺素水平在早老性ATD(P < 0.01)、53 - 57岁的唐氏综合征患者(P < 0.001)和27岁的唐氏综合征患者中比在老年性ATD中降低得更明显(下丘脑P < 0.05,乳头体,无显著差异)。早老性或老年性ATD患者尾状核中的多巴胺和HVA浓度未改变,但在年龄较大的唐氏综合征患者(27岁患者除外)中多巴胺降低(P < 0.01)。在ATD患者的嗅结节中,HVA水平未改变,但ChAT活性降低(P < 0.01)。ChAT活性在早老性ATD(P < 0.001)、年龄较大的唐氏综合征患者(P < 0.01)(年轻唐氏综合征患者除外)、老年性ATD(P < 0.001)的颞叶皮质以及早老性ATD(P < 0.001)和年龄较大的唐氏综合征患者(P < 0.001)(老年性ATD除外)的尾状核中降低。(摘要截断于250字)